Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:01 ET | Source: Replimune Group Inc WOBURN, Mass.,…
CITGO Sale Hearing Date Rescheduled to August 18, 2025
PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or…
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
IDEX Biometrics ASA: New date for the share consolidation and ISIN change
June 06, 2025 12:30 ET | Source: IDEX BIOMETRICS ASA Reference is…
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes
June 05, 2025 17:35 ET | Source: DENTSPLY SIRONA Inc. CHARLOTTE, N.C.,…
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 04, 2025 21:12 ET | Source: Helius Medical Technologies, Inc. NEWTOWN,…
Appili Therapeutics Announces Formal Termination of Arrangement Agreement with Aditxt Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN…
XCMG Opens 7th XCMG International Customer Festival, Strengthening Collaboration with Global Partners
XUZHOU, China, May 26, 2025 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE: 000425) has…
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited…
Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated…